amifostine anhydrous has been researched along with tiopronin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bisht, KS; Jagetia, GC; Kamath, G; Uma Devi, P | 1 |
| Prasanna, PG; Uma Devi, P | 2 |
| Devi, PU; Thomas, B | 1 |
| Thomas, B; Uma Devi, P | 1 |
| Kumar, S | 1 |
| Kumar, M; Kumar, S; Popli, MK; Uma Devi, P | 1 |
| Gupta, R; Uma Devi, P | 1 |
| Nagata, H | 1 |
| Bhanumathi, P; Devi, PU | 1 |
| Bisht, KS; Devi, PU; Vinitha, M | 1 |
2 review(s) available for amifostine anhydrous and tiopronin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.
Topics: Amifostine; Amino Acids, Sulfur; Animals; Drug Combinations; Humans; Mice; Neoplasms; Organothiophosphorus Compounds; Plant Extracts; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiotherapy; Tiopronin | 1985 |
11 other study(ies) available for amifostine anhydrous and tiopronin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Drug combination against single drug treatment in radiation protection of the bone marrow CFU.
Topics: Amifostine; Animals; Bone Marrow; Colony-Forming Units Assay; Drug Combinations; Mice; Organothiophosphorus Compounds; Radiation Dosage; Radiation Injuries, Experimental; Time Factors; Tiopronin; Whole-Body Irradiation | 1990 |
Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes.
Topics: Amifostine; Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Cobalt Radioisotopes; Drug Therapy, Combination; Mice; Mice, Inbred Strains; Radiation-Protective Agents; Tiopronin; Whole-Body Irradiation | 1990 |
Chromosome protection by WR-2721 and MPG-single and combination treatments.
Topics: Amifostine; Amino Acids, Sulfur; Animals; Chromosome Aberrations; Chromosomes; Cobalt Radioisotopes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Mice; Organothiophosphorus Compounds; Radiation-Protective Agents; Time Factors; Tiopronin; Whole-Body Irradiation | 1987 |
Bone marrow cell protection and modification of drug toxicity by combination of protectors.
Topics: Amifostine; Animals; Bone Marrow; Chromosome Aberrations; Drug Therapy, Combination; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Tiopronin | 1988 |
Studies on sulphydryl radioprotectors in mouse spleen and peripheral blood cells against gamma rays.
Topics: Amifostine; Amino Acids, Sulfur; Animals; Blood Cell Count; Cobalt Radioisotopes; Gamma Rays; Mice; Organothiophosphorus Compounds; Radiation-Protective Agents; Spleen; Tiopronin | 1985 |
Protection of mouse chromosomes against whole-body gamma irradiation by SH-compounds.
Topics: Amifostine; Amino Acids, Sulfur; Animals; Chromosome Aberrations; Gamma Rays; Male; Mice; Organothiophosphorus Compounds; Radiation Dosage; Radiation-Protective Agents; Tiopronin; Whole-Body Irradiation | 1986 |
Studies on sulfhydryl radioprotectors with low toxicities.
Topics: Amifostine; Animals; Cell Survival; Cells, Cultured; Humans; Male; Mice; Neoplasms; Radiation-Protective Agents; Radiotherapy, High-Energy; Sulfhydryl Compounds; Tiopronin | 1980 |
Modulation of glutathione depletion and lipid peroxidation by WR-77913 an 2-mercaptopropionylglycine in cyclophosphamide chemotherapy.
Topics: Amifostine; Animals; Cyclophosphamide; Female; Glutathione; Lipid Peroxidation; Male; Mice; Tiopronin | 1994 |
Modification of WR-2721 radiation protection from gastrointestinal injury and death in mice by 2-mercaptopropionylglycine.
Topics: Amifostine; Animals; Drug Therapy, Combination; Gastrointestinal Diseases; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Radiation-Protective Agents; Tiopronin; Whole-Body Irradiation | 1993 |
A comparative study of radioprotection by Ocimum flavonoids and synthetic aminothiol protectors in the mouse.
Topics: Amifostine; Animals; Bone Marrow; Chromosome Aberrations; Flavonoids; Mice; Plant Extracts; Radiation Injuries, Experimental; Radiation-Protective Agents; Tiopronin; Whole-Body Irradiation | 1998 |